Are Infant Reflux Drugs Worth the Risks?

FacebookTwitterGoogle+Email

The number of babies prescribed acid suppression drugs such as H2 blockers and PPIs grew 8-fold during 2002 to 2009, but fewer than 10% received any diagnostic testing for GERD (Gastroesophageal Reflux Disease). Some pediatricians are growing concerned that the “epidemic” of infant GERD cases is actually due to over-diagnosis, especially since clinical trials show acid blockers work no better than a placebo and can actually lead to short term and long term side effects. The FDA has not approved PPIs for treatment of GERD in children younger than one year.

The growth of GERD and reflux drugs for babies, infants and newborns. Are parents over-reacting to spit-up and crying?

Are Infant Reflux Drugs Worth the Risks? – An infographic by the team at Colic Calm

Embed “Are Infant Reflux Drugs Worth the Risks?” on Your Site: Copy and Paste the Code Below

Wide (800 pixels):

Narrow (500 pixels):

FacebookTwitterGoogle+Email

Comments are Disabled